ETHYL 2-BROMO-4-(TRIFLUOROMETHYL)OXAZOLE-5-CARBOXYLATE, 97.0%, 250mg

N,N-diisopropiletilamina, min 99%, per sintesi, 2,5 L, confezione in vetro

2-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid, 95.0%, 5g

Granulo di stagno 99,999% 2-4 mm 250 g

Methyl 5-phenylnicotinate, 98%, 5g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-isoleucine>98.0%(HPLC)(T)5g

Methyl 5-hydroxypiperidine-3-carboxylate hydrochloride, 95.0%, 100mg

2-Phenylcyclopropanamine, 90.0%, 5g

7'-CHLOROSPIRO[CYCLOPROPANE-1,3'-INDOLIN]-2'-ONE, 95.0%, 250mg

2,2'-Dinaphthylamine>98.0%(GC)1g

Tert-butyl7-(hydroxymethyl)-1-azaspiro[3.5]nonane-1-carboxylate, 98%, 250mg

4-Bromo-2-hydroxyphenylboronic acid, 98+%, 5g

tert-Butyl 1-benzyl-3-bromo-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxylate, 98%, 5g